Literature DB >> 27339824

Minimum 10-Year Follow-Up of Cementless Total Hip Arthroplasty Using a Contemporary Triple-Tapered Titanium Stem.

Samuel W Carlson1, Devon D Goetz2, Steve S Liu1, Justin J Greiner1, John J Callaghan1.   

Abstract

BACKGROUND: There is extensive variation in design and insertion technique of cementless tapered femoral stems. The purpose of our study was to evaluate a consecutive series of contemporary tapered cementless femoral stems inserted with a ream-and-broach technique at a minimum 10-year follow-up in patients undergoing total hip arthroplasty (THA).
METHODS: One hundred consecutive THAs (88 patients) performed by a single surgeon were followed for a minimum of 10 years. Hips were evaluated clinically for revision status, Western Ontario and McMaster Universities Osteoarthritis Index, 36-item Short Form Health Survey, Harris Hip Score, and University of California, Los Angeles, and Tegner Activity Scores. Radiographic evaluation included assessment for loosening, osteolysis, and stress shielding. Kaplan-Meier survivorship analysis included end points for revision and radiographic evidence of femoral component loosening.
RESULTS: At minimum 10-year follow-up, 66 patients (74 hips) were living, 20 patients (24 hips) were deceased, and 2 patients (2 hips) were lost to follow-up. Four hips required reoperation, but no femoral components were revised for aseptic loosening. One femoral component (1%) was revised due to a postoperative periprosthetic fracture. Radiographic evaluation demonstrated bone ingrowth of all stems without evidence of component loosening and 1 case of severe stress shielding. Kaplan-Meier survivorship at 10 years was 100% for the end points of femoral revision for loosening or femoral radiographic loosening.
CONCLUSION: This contemporary, cementless titanium-tapered femoral component inserted with ream-and-broach technique demonstrated excellent results in terms of outcomes and clinical durability as well as osteointegration on radiographs at minimum 10-year follow-up. This study corroborates, with level 2 and level 3 data, level 1 data reported in national registries.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cementless total hip arthroplasty; primary total hip arthroplasty; ream-and-broach; tapered stem

Mesh:

Substances:

Year:  2016        PMID: 27339824     DOI: 10.1016/j.arth.2016.04.037

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  5 in total

1.  Novel Bio-functional Magnesium Coating on Porous Ti6Al4V Orthopaedic Implants: In vitro and In vivo Study.

Authors:  Xiaokang Li; Peng Gao; Peng Wan; Yifeng Pei; Lei Shi; Bo Fan; Chao Shen; Xin Xiao; Ke Yang; Zheng Guo
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

2.  Biofunctional magnesium coated Ti6Al4V scaffold enhances osteogenesis and angiogenesis in vitro and in vivo for orthopedic application.

Authors:  Peng Gao; Bo Fan; Xiaoming Yu; Wenwen Liu; Jie Wu; Lei Shi; Di Yang; Lili Tan; Peng Wan; Yulin Hao; Shujun Li; Wentao Hou; Ke Yang; Xiaokang Li; Zheng Guo
Journal:  Bioact Mater       Date:  2020-05-12

Review 3.  Architected Materials for Additive Manufacturing: A Comprehensive Review.

Authors:  Nikolaos Kladovasilakis; Konstantinos Tsongas; Dimitris Karalekas; Dimitrios Tzetzis
Journal:  Materials (Basel)       Date:  2022-08-26       Impact factor: 3.748

4.  Long-term outcomes of a dual-mobility cup and cementless triple-taper femoral stem combination in total hip replacement: a multicenter retrospective analysis.

Authors:  Alain Cypres; Arnaud Fiquet; Philippe Girardin; David Fitch; Philippe Bauchu; Olivier Bonnard; Daniel Noyer; Christophe Roy
Journal:  J Orthop Surg Res       Date:  2019-11-21       Impact factor: 2.359

5.  Total hip arthroplasty utilizing an uncemented, flat, tapered stem with a reduced distal profile.

Authors:  Rachelle Morgenstern; Thomas Alastair Denova; Imraan Khan; Kaitlin M Carroll; Edwin P Su
Journal:  Arthroplast Today       Date:  2019-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.